Why Kymera Therapeutics Stock Popped This Week: Key Moves
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A concise guide to spotting tax-friendly dividend ETFs, including key metrics and quick tips to boost after-tax performance.
22,830 articlesA flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
New disclosures reveal a mixed picture: five Fortune 500 holdings drew public commentary in 2026, while two media nam...
SpaceX has joined the NASDAQ 100, but veteran skepticism remains. Famed investor jeremy gratham says today’s hype cou...
A veteran alchemy of service, fundraising and persistence, Lindsey Graham's rise illustrates how personal history int...
Could Amazon hit a $4 trillion market value by 2027? This guide breaks down the odds, drivers, and actionable moves f...
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
As 2026 approaches, the idea of an 18-year real estate cycle sparks questions for borrowers and investors. This guide...
A powerful winter storm has prompted an upgraded york city-area blizzard warning, raising concerns about heavy snowfa...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Tilray Brands is targeting a milestone $1.2 billion in annual revenue next year. This article digs into how the compa...
Could ford's f-150 lightning erev be the next expensive detour for Ford? This investing-focused guide breaks down how...
The Senate delivers a bipartisan win with the ROAD to Housing Act, yet observers say the measure only scratches the s...